Current viral risks of blood and blood products

被引：39

作者：

Dodd, RY ^{[1
]}

机构：

[1] Amer Red Cross, Holland Lab, Rockville, MD 20855 USA

来源：

ANNALS OF MEDICINE | 2000年 / 32卷 / 07期

关键词：

blood transfusion; hepatitis B virus; hepatitis C virus; HIV; human T-cell lymphotrophic retrovirus;

D O I：

10.3109/07853890009002022

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A number of viruses may be transmitted by blood transfusion, the most important of these are HIV, human T-cell lymphotrophic retrovirus (HTLV), hepatitis B virus (HBV), and hepatitis C virus (HCV). A series of overlapping safety measures are in place and are being improved and supplemented continuously. As a result, the risk of transmission of these viruses in the USA has been reduced to between one and four per million blood components transfused.

引用

收藏

页码：469 / 474

页数：6

相关论文

共 26 条

[1] SERUM ALANINE AMINOTRANSFERASE OF DONORS IN RELATION TO THE RISK OF NON-A,NON-B HEPATITIS IN RECIPIENTS - THE TRANSFUSION-TRANSMITTED VIRUSES STUDY [J].

AACH, RD ;

SZMUNESS, W ;

MOSLEY, JW ;

HOLLINGER, FB ;

KAHN, RA ;

STEVENS, CE ;

EDWARDS, VM ;

WERCH, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (17) :989-994

[2] DONOR TRANSAMINASE AND RECIPIENT HEPATITIS - IMPACT ON BLOOD-TRANSFUSION SERVICES [J].

ALTER, HJ ;

PURCELL, RH ;

HOLLAND, PV ;

ALLING, DW ;

KOZIOL, DE .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (06) :630-634

[3]

Alter HJ, 1987, TRANSFUSION TRANSMIT, P53

[4]

Alter Miriam J., 1995, P23

[5] The transfusion-associated transmission of parvovirus B19 [J].

Azzi, A ;

Morfini, M ;

Mannucci, PM .

TRANSFUSION MEDICINE REVIEWS, 1999, 13 (03) :194-204

[6] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS) [J].

BARRESINOUSSI, F ;

CHERMANN, JC ;

REY, F ;

NUGEYRE, MT ;

CHAMARET, S ;

GRUEST, J ;

DAUGUET, C ;

AXLERBLIN, C ;

VEZINETBRUN, F ;

ROUZIOUX, C ;

ROZENBAUM, W ;

MONTAGNIER, L .

SCIENCE, 1983, 220 (4599) :868-871

[7] A COMPARISON OF FILTERED LEUKOCYTE-REDUCED AND CYTOMEGALOVIRUS (CMV) SERONEGATIVE BLOOD PRODUCTS FOR THE PREVENTION OF TRANSFUSION-ASSOCIATED CMV INFECTION AFTER MARROW TRANSPLANT [J].

BOWDEN, RA ;

SLICHTER, SJ ;

SAYERS, M ;

WEISDORF, D ;

CAYS, M ;

SCHOCH, G ;

BANAJI, M ;

HAAKE, R ;

WELK, K ;

FISHER, L ;

MCCULLOUGH, J ;

MILLER, W .

BLOOD, 1995, 86 (09) :3598-3603

[8] EVALUATION OF SCREENED BLOOD DONATIONS FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION BY CULTURE AND DNA AMPLIFICATION OF POOLED CELLS [J].

BUSCH, MP ;

EBLE, BE ;

KHAYAMBASHI, H ;

HEILBRON, D ;

MURPHY, EL ;

KWOK, S ;

SNINSKY, J ;

PERKINS, HA ;

VYAS, GN .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (01) :1-5

[9] Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection [J].

Busch, MP ;

Korelitz, JJ ;

Kleinman, SH ;

Lee, SR ;

AuBuchon, JP ;

Schreiber, GB ;

Williams, AE ;

Ownby, HE ;

Waxman, DA ;

Hutching, S ;

Murphy, EL ;

Gilcher, RO ;

Smith, JW ;

Thomson, RA ;

Nemo, GJ ;

Zuck, TF .

TRANSFUSION, 1995, 35 (11) :903-910

[10] RISK OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TRANSMISSION BY BLOOD-TRANSFUSIONS BEFORE THE IMPLEMENTATION OF HIV-1 ANTIBODY SCREENING [J].

BUSCH, MP ;

YOUNG, MJ ;

SAMSON, SM ;

MOSLEY, JW ;

WARD, JW ;

PERKINS, HA .

TRANSFUSION, 1991, 31 (01) :4-11